Cathepsin Activity-Based Probes and Inhibitor for Preclinical Atherosclerosis Imaging and Macrophage Depletion

• Ihab Abd-Elrahman,

  Affiliation The Institute of Drug Research, The School of Pharmacy, The Faculty of Medicine, The Hebrew University, Jerusalem, 9112001, Israel

  ⨯
• Hisanori Kosuge,

  Current address: Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, 1138519, Japan

  Affiliation Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, 94305, United States of America

  ⨯
• Tommy Wises Sadan,

  Affiliation The Institute of Drug Research, The School of Pharmacy, The Faculty of Medicine, The Hebrew University, Jerusalem, 9112001, Israel

  ⨯
• Yael Ben-Nun,

  Affiliation The Institute of Drug Research, The School of Pharmacy, The Faculty of Medicine, The Hebrew University, Jerusalem, 9112001, Israel

  ⨯
• Karen Meir,

  Affiliation Department of Pathology, Hadassah Medical Center, Jerusalem, 9112001, Israel

  ⨯
• Chen Rubinstein,

  Affiliation Departments of Vascular Surgery, Hadassah Medical Center, Jerusalem, 9112001, Israel

  ⨯
• Matthew Bogyo,

  Affiliation Department of Pathology and Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, 94305, United States of America

  ⨯
• Michael V. McConnell,

  Affiliation Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, 94305, United States of America

  ⨯
• Galia Blum

  * E-mail: galiabl@ekmd.huji.ac.il

  Affiliation The Institute of Drug Research, The School of Pharmacy, The Faculty of Medicine, The Hebrew University, Jerusalem, 9112001, Israel

  ⨯